Transradial access products market seen reaching $4.39 billion by 2030

The transradial access products market is projected to grow from $2.47 billion in 2025 to $2.77 billion in 2026, with North America leading the market. The Business Research Company says rising cardiovascular disease, more angiography procedures and a shift to minimally invasive cardiology are driving the outlook.

Why it matters: - The market is tied to a growing need for less invasive cardiovascular procedures that can reduce complications and speed recovery. - Demand is rising as heart disease rates increase and hospitals expand catheter-based care. - The market’s growth points to continued investment in interventional cardiology tools and training.

What happened: - The Business Research Company released a report on the global transradial access products market on September 1, 2026. - The market is projected to rise from $2.47 billion in 2025 to $2.77 billion in 2026. - The report forecasts the market will reach $4.39 billion by 2030. - North America was the largest regional market in 2025.

The details: - Transradial access products are medical tools used to access the circulatory system through the radial artery in the wrist. - The products are used in cardiology procedures including coronary angiography and angioplasty. - The technique lets physicians perform catheter-based interventions with less invasiveness than femoral artery access. - Historical growth has been driven by more coronary artery disease, more angiography procedures, expansion of hospital catheterization labs, clinical success with radial access and wider physician training. - The report lists future growth drivers as broader use of minimally invasive cardiology, more outpatient procedures, innovation in guidewire materials, greater emphasis on patient safety and growth in cardiac procedures worldwide. - The report highlights an ongoing shift from femoral access to radial access, fewer post-procedure complications, advances in interventional cardiology, improved hemostatic device designs and faster patient recovery. - The report identifies cardiovascular diseases as a major growth factor, including coronary artery disease, heart failure and stroke. - Lifestyle factors such as sedentary habits, poor nutrition, obesity, smoking, excessive alcohol intake and aging populations are linked to higher rates of hypertension, diabetes and related risk factors. - The American Heart Association reported in January 2024 that the age-adjusted death rate from cardiovascular disease in the US rose to 233.3 per 100,000 people, up 4.0% from 224.4 per 100,000 in 2023. - The market analysis also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The report frames radial access as part of a broader move in cardiology toward procedures that are easier on patients and more efficient for providers. - North America’s lead suggests the region’s healthcare infrastructure and adoption of minimally invasive techniques remain ahead of other markets. - The inclusion of market-attractiveness scoring, TAM analysis and forecasting dashboards signals that the report is aimed at investors and companies tracking where growth is strongest.

What's next: - The market is expected to keep expanding as cardiac care shifts toward outpatient settings and minimally invasive procedures. - Product development will likely focus on guidewire materials, hemostatic devices and other tools that support safer and faster procedures. - Regional growth will continue to depend on local cardiovascular disease burden, infrastructure and adoption of radial access techniques. - More information is available in the sample report and the full market report.